Skip to content

Insider · CIK 0001903716

Rajavelu Esther

Reports to the SEC for 2 companies · CAMBRIDGE, MA

Transactions

17

Companies

2

Filings

11

CIK

0001903716

Forms 4 and 5

Insider transactions

17 trades
DateCompanyValue
2026-05-04SPROSpero Therapeutics, Inc.S Sale−$63.4K
2026-02-06SPROSpero Therapeutics, Inc.S Sale−$87.6K
2026-02-06SPROSpero Therapeutics, Inc.S Sale−$120K
2026-02-02SPROSpero Therapeutics, Inc.A Award—
2026-02-02SPROSpero Therapeutics, Inc.S Sale−$40.6K
2026-02-02SPROSpero Therapeutics, Inc. · Stock Option (Right to Buy)A Award—
2025-11-07SPROSpero Therapeutics, Inc.S Sale−$95.4K
2025-05-02SPROSpero Therapeutics, Inc.A Award—
2025-02-05SPROSpero Therapeutics, Inc.S Sale−$16.1K
2025-02-03SPROSpero Therapeutics, Inc.A Award—
2025-02-03SPROSpero Therapeutics, Inc.A Award—
2024-11-08SPROSpero Therapeutics, Inc.S Sale−$22.4K
2024-11-07SPROSpero Therapeutics, Inc.S Sale−$30.6K
2024-02-01SPROSpero Therapeutics, Inc.A Award—
2023-11-13SPROSpero Therapeutics, Inc.A Award—
2023-02-09FULCFulcrum Therapeutics, Inc. · Stock Option (right to buy)A Award—
2022-01-03FULCFulcrum Therapeutics, Inc. · Stock Option (right to buy)A Award—

Recent filings

11

Companies

2

Address

C/O SPERO THERAPEUTICS, INC. 675 MASSACHUSETTS AVENUE, 14TH FLOOR

CAMBRIDGE, MA, 02139